Full Text View
Tabular View
No Study Results Posted
Related Studies
Management of Vaginal Complaints
This study is not yet open for participant recruitment.
Verified by Agency for Healthcare Research and Quality (AHRQ), November 2006
First Received: July 17, 2007   No Changes Posted
Sponsored by: Agency for Healthcare Research and Quality (AHRQ)
Information provided by: Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier: NCT00503542
  Purpose

Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.


Condition Intervention Phase
Vaginitis
Drug: Empiric therapy for candidiasis or bacterial vaginosis
Phase 0

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network

Resource links provided by NLM:


Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:
  • Self-reported improvement in symptoms

Secondary Outcome Measures:
  • Adverse reactions to treatment.
  • Incidence of STD's
  • Vaginal Complaints Scale

Study Start Date: December 2006
Estimated Study Completion Date: May 2007
Detailed Description:

Setting: The study will be carried out at two sites within the New York City Research and Improvement Network (NYC RING) an urban Practice Based Research Network comprising 21 clinical sites. Problem: Vaginal symptoms are the most common reason for outpatient gynecological consultation, yet the management of these symptoms is not well grounded in evidence from primary care. Purpose: To prepare for a randomized clinical trial (RCT) to test whether the current standard of care for evaluating vaginal symptoms (which involves looking for specific pathogens) produces better clinical outcomes than a simpler approach, which treats patients based on their symptoms. Methods: 55 premenopausal non-pregnant adult women presenting with vaginal complaints will be randomized into two groups. Women in Group A will be managed on the basis of presenting complaint without physical examination or office laboratory work. Women in Group B will receive a physical examination and office evaluation looking for trichomonads, candida and bacterial vaginosis. They will be managed according to the clinical and office laboratory findings. Patients will be contacted by phone two weeks after consultation to assess symptom resolution, adverse reaction to drugs, satisfaction with care and treatment experiences. Patients will be screened for infection with gonorrhea and chlamydia using a urine antigen test and for trichomoniasis using vaginal culture. Patients whose tests demonstrate trichomoniasis, chlamydia or gonorrhea or who remain symptomatic at the two-week follow-up call will be re-evaluated promptly. Outcomes: AIM 1: Feasibility: The pilot will assess 1) ability to recruit and retain patients, 2) acceptability of study protocols to subjects and 3) prevalence and detection of important sexually transmitted diseases (STD’s). AIM 2: Initial evidence of effectiveness: The pilot will provide data on key planned RCT outcome measurements including 1) treatment success rates (allowing estimation of future sample size), 2) need for reconsultation 3) adverse reactions, 4) medication usage and 5) patient satisfaction. Benefit to public health: This pilot study will lead to a RCT of the management of vaginal complaints in primary care. This RCT may support current practice, reinforcing the need for physical exam and laboratory testing in all patients. On the other hand, the trial may support a more limited approach that avoids a pelvic examination. This could result in substantial savings of health care dollars with equivalent clinical outcomes.

  Eligibility

Ages Eligible for Study:   18 Years to 52 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Eligible patients will be premenopausal, non-pregnant women presenting with a chief complaint of vaginal itch, malodor, discharge, pain, irritation or rash. We will accept patient history of being pre-menopausal as valid.

Exclusion Criteria:

  • We will exclude women over 45 who have undergone hysterectomy. We will exclude patients who cannot be reached by phone for follow-up interviews. We will exclude pregnant women because of concerns that the diagnosis and treatment of bacterial vaginosis plays a role in pre-term labor prevention.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00503542

Contacts
Contact: Matthew R Anderson, MD, MSc 718 933-2400 ext 644 bronxdoc@gmail.com

Sponsors and Collaborators
Investigators
Principal Investigator: Matthew R. Anderson, MD, MSc Montefiore Medical Center
  More Information

No publications provided

Study ID Numbers: 1 R03 HS016050-01
Study First Received: July 17, 2007
Last Updated: July 17, 2007
ClinicalTrials.gov Identifier: NCT00503542     History of Changes
Health Authority: United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):
Vaginitis
Bacterial Vaginosis
Vaginal trichomoniasis
Vulvovaginal candidiasis

Study placed in the following topic categories:
Genital Diseases, Female
Vaginosis, Bacterial
Candidiasis, Vulvovaginal
Candidiasis
Vaginitis
Trichomonas Infections
Vaginal Diseases
Trichomonas Vaginitis

Additional relevant MeSH terms:
Genital Diseases, Female
Vaginitis
Vaginal Diseases

ClinicalTrials.gov processed this record on September 11, 2009